AU · Healthcare

Nexsen Limited (NXN)

Biotechnology

Nexsen Limited (NXN) is listed on AU in the Healthcare sector. Industry: Biotechnology. As of 2026-05-17, reported market cap is $45.04M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for NXN

Market cap
$45.04M
P/E ratio
18.00
Gross profit (TTM)
$-2.27M
Net margin
0.0%

Nexsen Limited (NXN) — FAQ

What is Nexsen Limited's market cap?

Nexsen Limited (NXN) has a reported market cap of $45.04M (data as of 2026-05-17).

What is NXN's P/E ratio?

The price-to-earnings (P/E) ratio for Nexsen Limited (NXN) is 18.00 (data as of 2026-05-17).

Does Nexsen Limited pay a dividend?

Dividend yield is not available in the current snapshot for Nexsen Limited (NXN). Check the MyAverix Finance app for the latest dividend data.

What sector is Nexsen Limited in?

Nexsen Limited (NXN) is classified in the Healthcare sector (Biotechnology industry).

What exchange is NXN listed on?

NXN is listed on AU.

What is Nexsen Limited's net margin?

Nexsen Limited (NXN) reports a net margin of 0.0% (data as of 2026-05-17).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play